On 22 May 2017, Federal Minister of Health, Hermann Gröhe, attended the World Health Assembly (WHA) in Geneva. This year's priorities are the election of a new Director-General as well as the vote on the draft 2018 – 2019 Budget.
At the invitation of Federal Minister of Health Hermann Gröhe, the first Meeting of Health Ministers of the Group of Twenty leading industrialised and emerging economies (G20) took place in Berlin on 19 and 20 May 2017.
On his trip to the USA from 12 to 15 March 2017, Federal Minister of Health Hermann Gröhe presented the agenda of Germany’s G20 Presidency. Further major topics on the programme were cancer research, the international fight against antimicrobial resistance (AMR) and the preparedness for cross-border health emergencies.
The Health ministers and secretaries of the ‘Global Health Security Initiative’ (GHSI) met in Brussels on 24th February for their 17th Ministerial Meeting. The focus was on the collaboration between the health and security sectors in preparing for and responding to health emergencies caused by terrorist attacks and on international crisis management to mitigate global public health emergencies.
Each year, the World Economic Forum in Davos offers a welcome opportunity to discuss global challenges. Federal Minister of Health Hermann Gröhe is attending the Forum to push for international strategies against antimicrobial resistance and international health emergencies.
Federal Minister of Health Hermann Gröhe had co-chaired the Health Ministerial Meeting of the Organisation for Economic Cooperation and Development (OECD) in Paris from 16 to 17 January. He singled out two central issues that must be awarded greater attention in the OECD context: the fight against AMR and intensifying the global exchange on patient safety.
On December 1, 2016, Germany has taken over the presidency of the G20. One priority of the German G20 presidency will be global health. And in 2017, we will see the first ever G20 health ministers’ meeting.
The company Biotest has recalled batches of the medicinal products Albumin 5% and 20% over a quality defect. Doctors and pharmacists have already been alerted to this recall. The Paul-Ehrlich-Institut is in contact with the EU authorities.
Patient safety must be the single most important theme in taking our health care system further. Federal Minister of Health Hermann Gröhe hosted the Second Global Ministerial Summit on Patient Safety in Bonn on 29/30 March 2017.